CCLA Investment Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,423,010
| Closed | -$133M | – | 62 |
|
|
2024
Q3 | $133M | Hold |
1,423,010
| – | – | 2.04% | 13 |
|
|
2024
Q2 | $133M | Buy |
1,423,010
+16,296
| +1% | +$1.52M | 2.04% | 13 |
|
|
2024
Q1 | $134M | Buy |
1,406,714
+1,405,319
| +100,740% | +$134M | 2.06% | 13 |
|
|
2023
Q4 | $107M | Sell |
1,395
-1,279,930
| -100% | -$98.2B | 1.75% | 27 |
|
|
2023
Q3 | $88.8M | Buy |
1,281,325
+25,770
| +2% | +$1.79M | 1.66% | 28 |
|
|
2023
Q2 | $118M | Buy |
1,255,555
+92,090
| +8% | +$8.68M | 2.11% | 12 |
|
|
2023
Q1 | $96.1M | Buy |
1,163,465
+96,873
| +9% | +$8M | 1.89% | 19 |
|
|
2022
Q4 | $79.6M | Buy |
1,066,592
+259,051
| +32% | +$19.3M | 1.8% | 23 |
|
|
2022
Q3 | $66.9M | Buy |
+807,541
| New | +$66.9M | 1.62% | 30 |
|
|
2022
Q1 | $94.6M | Buy |
802,978
+12,198
| +2% | +$1.44M | 1.7% | 23 |
|
|
2021
Q4 | $102M | Sell |
790,780
-47,157
| -6% | -$6.11M | 1.68% | 25 |
|
|
2021
Q3 | $94.9M | Buy |
837,937
+84,739
| +11% | +$9.59M | 1.57% | 27 |
|
|
2021
Q2 | $78K | Buy |
753,198
+188,568
| +33% | +$19.5K | 0.95% | 39 |
|
|
2021
Q1 | $47.2M | Buy |
564,630
+132,070
| +31% | +$11M | 0.94% | 51 |
|
|
2020
Q4 | $39M | Buy |
432,560
+3,790
| +0.9% | +$342K | 0.88% | 55 |
|
|
2020
Q3 | $34.2M | Buy |
+428,770
| New | +$34.2M | 0.93% | 49 |
|